Polysialogangliosides Expressed by Amelanotic Melanoma: A Possible Explanation for the Poor Response to Anti‐monosialoganglioside Antibody 202 in a Patient with Melanoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1346-8138|22|2|81-87

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.22, Iss.2, 1995-02, pp. : 81-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strong Anti‐tumor Effect of Monosialoganglioside Specific Monoclonal Antibody 202: A Clinical Trial in a Cancer Patient with Melanoma

By  

THE JOURNAL OF DERMATOLOGY, Vol. 16, Iss. 6, 1989-12 ,pp. : 480-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary Amelanotic Melanoma of the Vagina

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-08 ,pp. : 474-476

Karger

Access to resources Recommend Favorite

SUBUNGUAL AMELANOTIC MALIGNANT MELANOMA

By  

THE JOURNAL OF DERMATOLOGY, Vol. 12, Iss. 6, 1985-12 ,pp. : 530-533

John Wiley & Sons Inc

Access to resources Recommend Favorite

AN AMELANOTIC MELANOMA TRANSFORMED INTO MELANOTIC MELANOMA WITH DEVELOPMENT OF VITILIGO

By  

THE JOURNAL OF DERMATOLOGY, Vol. 8, Iss. 6, 1981-12 ,pp. : 431-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Amelanotic Bone Marrow Infiltration Secondary to Pigmented Malignant Melanoma

By  

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 8, 1995-08 ,pp. : 620-622

John Wiley & Sons Inc

Access to resources Recommend Favorite